PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.\', \'Microbiology Department, Hospital Clínic, University of Barcelona, Barcelona, Spain.\', \'Pharmacy Service, Division of Medicines, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.\', \'Infectious Disease Service, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/jvh.13410
?:doi
?:hasPublicationType
?:journal
  • Journal of viral hepatitis
is ?:pmid of
?:pmid
?:pmid
  • 32969557
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.683
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all